Taiwan
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.57
|
Dec. 31, 2023 | USD 4.63 | NA |
|
Taiwan |
|
2 |
1.42
|
Dec. 31, 2023 | USD 2.07 | NA |
|
Taiwan |
|
3 |
0.81
|
Dec. 31, 2023 | USD 1.34 | NA |
|
Taiwan |
|
4 |
0.67
|
Dec. 31, 2023 | USD 7.84 | NA |
|
Taiwan |
|
5 |
0.54
|
Dec. 31, 2023 | USD 2.22 | NA |
|
Taiwan |
|
6 |
0.51
|
Dec. 31, 2023 | USD 1.58 | NA |
|
Taiwan |
|
7 |
0.29
|
Dec. 31, 2023 | USD 2.60 | NA |
|
Taiwan |
|
8 |
0.28
|
Dec. 31, 2023 | USD 1.24 | NA |
|
Taiwan |
|
9 |
0.28
|
Dec. 31, 2023 | USD 3.66 | NA |
|
Taiwan |
|
10 |
0.25
|
Dec. 31, 2023 | USD 1.26 | NA |
|
Taiwan |
|
11 |
0.22
|
Dec. 31, 2023 | USD 0.69 | NA |
|
Taiwan |
|
12 |
0.20
|
Dec. 31, 2023 | USD 2.55 | NA |
|
Taiwan |
|
13 |
0.17
|
Dec. 31, 2023 | USD 2.59 | NA |
|
Taiwan |
|
14 |
0.13
|
Dec. 31, 2023 | USD 1.81 | NA |
|
Taiwan |
|
15 |
0.07
|
Dec. 31, 2023 | USD 0.34 | NA |
|
Taiwan |
|
16 |
0.06
|
Dec. 31, 2023 | USD 0.68 | NA |
|
Taiwan |
|
17 |
0.05
|
Dec. 31, 2023 | USD 0.97 | NA |
|
Taiwan |
|
18 |
0.03
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Taiwan |
|
19 |
0.01
|
Dec. 31, 2023 | USD 0.49 | NA |
|
Taiwan |
|
20 |
0.01
|
Dec. 31, 2023 | USD 0.95 | NA |
|
Taiwan |
|
21 |
0.00
|
Dec. 31, 2023 | USD 3.03 | NA |
|
Taiwan |
The Healthcare company in Taiwan with the highest Debt to Equity Ratio is Great Tree Pharmacy Co., Ltd. (Taipei Exchange: 6469.TWO) at 1.57.
The Healthcare company in Taiwan with the lowest Debt to Equity Ratio is PharmaEngine, Inc. (Taipei Exchange: 4162.TWO) at 0.00.
The top 10 Healthcare companies in Taiwan by Debt to Equity Ratio are Great Tree Pharmacy Co., Ltd., Bionime Corporation, CHC Healthcare Group, Lotus Pharmaceutical Co., Ltd., Formosa Laboratories, Inc., Medigen Vaccine Biologics Corporation, TaiMed Biologics Inc., Center Laboratories, Inc., Bioteque Corporation and Nang Kuang Pharmaceutical Co., Ltd..
The bottom 10 Healthcare companies in Taiwan by Debt to Equity Ratio are PharmaEngine, Inc., Abnova (Taiwan) Corporation, PhytoHealth Corporation, Oneness Biotech Co., Ltd., Microbio Co., Ltd., ScinoPharm Taiwan, Ltd., TaiGen Biopharmaceuticals Holdings Limited, OBI Pharma, Inc., Excelsior Medical Co., Ltd. and SCI Pharmtech, Inc..